Expression and Function of Ferroportin 1 in O-2A Progenitor Cells

Anatomical Record

Volumn 296, Issue 1, 2013, Pages 108-116

  Lin, Qing ^a   Feng, Junsheng ^a   Zhao, Xiaozhen ^a   Zhang, Geng ^a   Wang, Wei ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Ferroportin 1; Iron; O 2A progenitor cells

Indexed keywords

CALCEIN; FERRITIN; FERROPORTIN 1; FERROPORTIN 1 ANTIBODY; MESSENGER RNA; PROTEIN ANTIBODY; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; IRON TRANSPORT; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RNA ANALYSIS; STEM CELL;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, MONOCLONAL; CATION TRANSPORT PROTEINS; CELL MEMBRANE; CELLS, CULTURED; CYTOPLASM; FERRITINS; IRON; OLIGODENDROGLIA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TRANSFERRIN; STEM CELLS;

LENTIVIRUS; RATTUS;

EID: 84871650414     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.22610     Document Type: Article

References (39)

1. Abboud S, Haile DJ. 2000. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275: 19906-19912.
2. Andrews NC. 1999. Disorders of iron metabolism. N Engl J Med 341: 1986-1995.
3. Arosio P, Ingrassia R, Cavadini P. 2009. Ferritins: a family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta 1790: 589-599.
4. Asou H, Hamada K, Miyazaki T, Sakota T, Hayashi K, Takeda Y, Marret S, Delpech B, Itoh K, Uyemura K. 1995. CNS myelinogenesis in vitro: time course and pattern of rat oligodendrocyte development. J Neurosci Res 40: 519-534.
5. Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, Arvin KL, Holtzman DM. 2002. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 22: 455-463.
6. Beaino G, Khoshnood B, Kaminski M, Pierrat V, Marret S, Matis J, Ledésert B, Thiriez G, Fresson J, Rozé JC, Zupan-Simunek V, Arnaud C, Burguet A, Larroque B, Bréart G, Ancel PY. 2010. Predictors of cerebral palsy in very preterm infants: the EPIPAGE prospective population-based cohort study. Dev Med Child Neurol 52: e119-e125.
7. Blomberg MR, Siegbahn PE, Wikstrom M. 2003. Metal-bridging mechanism for O-O bond cleavage in cytochrome C oxidase. Inorg Chem 42: 5231-5243.
8. Burdo JR, Menzies SL, Simpson IA, Garrick LM, Garrick MD, Dolan KG, Haile DJ, Beard JL, Connor JR. 2001. Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J Neurosci Res 66: 1198-1207.
9. Chen Y, Qian ZM, Du J, Duan X, Chang Y, Wang Q, Wang C, Ma YM, Xu Y, Li L, Ke Y. 2005. Iron loading inhibits ferroportin1 expression in PC12 cells. Neurochem Int 47: 507-513.
10. Connor JR, Pavlick G, Karli D. 1995. A histochemical study of iron-positive cells in the developing rat brain. J Comp Neurol 355: 111-123.
11. De Domenico I, Ward DM, Nemeth E, Vaughn MB, Musci G, Ganz T, Kaplan J. 2005. The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci USA 102: 8955-8960.
12. Dietrich RB, Bradley WG, Jr. 1988. Iron accumulation in the basal ganglia following severe ischemic-anoxic insults in children. Radiology 168: 203-206.
13. Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus GS, Pinkus JL, Kingsley PD, Palis J, Fleming MD, Andrews NC, Zon LI. 2000. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403: 776-781.
14. Doyle LW, Roberts G, Anderson PJ. 2010. Outcomes at age 2 years of infants < 28 weeks' gestational age born in Victoria in 2005. J Pediatr 156: 49-53.
15. Fleming RE, Bacon BR. 2005. Orchestration of iron homeostasis. N Engl J Med 352: 1741-1744.
16. Ganz T. 2005. Cellular iron: ferroportin is the only way out. Cell Metab 1: 155-157.
17. Gordon N. 2003. Iron deficiency and the intellect. Brain Dev 25: 3-8.
18. Groenendaal F, Termote JU, van der Heide-Jalving M, van Haastert IC, de Vries LS. 2010. Complications affecting preterm neonates from 1991 to 2006: what have we gained? Acta Paediatr 99: 354-358.
19. Hentze MW, Muckenthaler MU, Galy B, Camaschella C. 2010. Two to tango: regulation of Mammalian iron metabolism. Cell 142: 24-38.
20. Kakhlon O, Cabantchik ZI. 2002. The labile iron pool: characterization, measurement, and participation in cellular processes (1). Free Radic Biol Med 33: 1037-1046.
21. Khwaja O, Volpe JJ. 2008. Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonatal Ed 93: F153-F161.
22. Knutson MD, Oukka M, Koss LM, Aydemir F, Wessling-Resnick M. 2005. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc Natl Acad Sci USA 102: 1324-1328.
23. Lachapelle F, Avellana-Adalid V, Nait-Oumesmar B, Baron-Van Evercooren A. 2002. Fibroblast growth factor-2 (FGF-2) and platelet-derived growth factor AB (PDGF AB) promote adult SVZ-derived oligodendrogenesis in vivo. Mol Cell Neurosci 20: 390-403.
24. Li L, Li YW, Zhao JY, Liu YZ, Holscher C. 2009. Quantitative analysis of iron concentration and expression of ferroportin 1 in the cortex and hippocampus of rats induced by cerebral ischemia. J Clin Neurosci 16: 1466-1472.
25. Lv Z, Jiang H, Xu H, Song N, Xie J. 2011. Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease. J Neural Transm 118: 361-369.
26. McClure MM, Riddle A, Manese M, Luo NL, Rorvik DA, Kelly KA, Barlow CH, Kelly JJ, Vinecore K, Roberts CT, Hohimer AR, Back SA. 2008. Cerebral blood flow heterogeneity in preterm sheep: lack of physiologic support for vascular boundary zones in fetal cerebral white matter. J Cereb Blood Flow Metab 28: 995-1008.
27. McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, Simpson RJ. 2000. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5: 299-309.
28. Munck P, Haataja L, Maunu J, Parkkola R, Rikalainen H, Lapinleimu H, Lehtonen L. 2010. Cognitive outcome at 2 years of age in Finnish infants with very low birth weight born between 2001 and 2006. Acta Paediatr 99: 359-366.
29. Muñoz Gómez M, Campos Garríguez A, García Erce JA, Ramírez Ramírez G. 2005. Fisiopathology of iron metabolism: diagnostic and therapeutic implications. Nefrologia 25: 9-19.
30. Qian ZM, Shen X. 2001. Brain iron transport and neurodegeneration. Trends Mol Med 7: 103-108.
31. Ramsey AJ, Hillas PJ, Fitzpatrick PF. 1996. Characterization of the active site iron in tyrosine hydroxylase. Redox states of the iron. J Biol Chem 271: 24395-24400.
32. Rathnasamy G, Ling EA, Kaur C. 2011. Iron and iron regulatory proteins in amoeboid microglial cells are linked to oligodendrocyte death in hypoxic neonatal rat periventricular white matter through production of proinflammatory cytokines and reactive oxygen/nitrogen species. J Neurosci 31: 17982-17995.
33. Riddle A, Luo NL, Manese M, Beardsley DJ, Green L, Rorvik DA, Kelly KA, Barlow CH, Kelly JJ, Hohimer AR, Back SA. 2006. Spatial heterogeneity in oligodendrocyte lineage maturation and not cerebral blood flow predicts fetal ovine periventricular white matter injury. J Neurosci 26: 3045-3055.
34. Sävman K, Nilsson UA, Thoresen M, Kjellmer I. 2005. Non-protein-bound iron in brain interstitium of newborn pigs after hypoxia. Dev Neurosci 27: 176-184.
35. Song N, Wang J, Jiang H, Xie J. 2010. Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease. Free Radic Biol Med 48: 332-341.
36. Takeshima T, Johnston JM, Commissiong JW. 1994. Oligodendrocyte-type-2 astrocyte (O-2A) progenitors increase the survival of rat mesencephalic, dopaminergic neurons from death induced by serum deprivation. Neurosci Lett 166: 178-182.
37. Volpe JJ, Kinney HC, Jensen FE, Rosenberg PA. 2011. The developing oligodendrocyte: key cellular target in brain injury in the premature infant. Int J Dev Neurosci 29: 423-440.
38. Vranka JA, Sakai LY, Bachinger HP. 2004. Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes. J Biol Chem 279: 23615-23621.
39. Wu LJ, Leenders AG, Cooperman S, Meyron-Holtz E, Smith S, Land W, Tsai RY, Berger UV, Sheng ZH, Rouault TA. 2004. Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier. Brain Res 1001: 108-117.